Bellissimo Dana C, Speck Nancy A
Department of Cell and Developmental Biology, Perelman School of Medicine, Abramson Family Cancer Research Institute, Institute for Regenerative Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Front Cell Dev Biol. 2017 Dec 20;5:111. doi: 10.3389/fcell.2017.00111. eCollection 2017.
is a recurrently mutated gene in sporadic myelodysplastic syndrome and leukemia. Inherited mutations in cause familial platelet disorder with predisposition to acute myeloid leukemia (FPD/AML). In sporadic AML, mutations in are usually secondary events, whereas in FPD/AML they are initiating events. Here we will describe mutations in in sporadic AML and in FPD/AML, discuss the mechanisms by which inherited mutations in could elevate the risk of AML in FPD/AML individuals, and speculate on why mutations in are rarely, if ever, the first event in sporadic AML.
是散发性骨髓增生异常综合征和白血病中反复发生突变的基因。该基因的遗传突变会导致家族性血小板疾病并易患急性髓系白血病(FPD/AML)。在散发性急性髓系白血病中,该基因的突变通常是继发事件,而在FPD/AML中它们是起始事件。在此,我们将描述散发性急性髓系白血病和FPD/AML中该基因的突变情况,讨论该基因的遗传突变在FPD/AML个体中增加急性髓系白血病风险的机制,并推测为何该基因的突变在散发性急性髓系白血病中极少(如果有的话)是首发事件。